A review. The systematic development of the RAPTA family of organometallic ruthenium(II) anticancer drugs contg. a monodentate 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane ligand and a h6-arene ligand is described.
Christian Heinis, Xinjian Ji, Alexander Lund Nielsen
Paul Joseph Dyson, Irina Sinenko, Roland Christopher Turnell-Ritson
Giovanni De Cesare, Romain Maxime Dubuis, Robin Schroff